Epinephrine
by Melanie Jones
1. Name/Classification
1.1. Therapeutic Class: Anti-asthmatics, Vasopressors, Bronchodialator
1.2. Pharmacological Class: Adrenergics
1.3. Drug Name: Epinephrine
1.4. Brand Names: Adrenalin, Allerject, Anapen, Epipen
2. Dose
2.1. Subcut/IM;Adults: 0.1-0.5 mg single dose (do not exceed 1mg) Repeat q 10-15 min for anaphyactic shock; q 20 min-4 hr for asthma
2.1.1. Inhalation; Adults: 1 inhalation of 1% solution repeat q 1-2 min up to 4-6 times daily
2.1.1.1. IV; Adults: 0.1-0.25 mg q 5-15 min for severe anaphylaxis; 1 mg q 3-5 min for cardiopulmonary resuscitation; 2-10 mg/min for bradycardia
2.1.1.1.1. Intracardiac; Adults; 0.3-0.5 mg
2.2. Subcut; Children >1 Month; 0.01 mg/kg (do not exceed 0.5 mg) q 15 min for 2 doses, then q 4 hr for anaphylactic reactions/asthma
2.2.1. Inhalation; Children: 0.25-0.5 ml of 2.25% racemic epinephrine solution diluted in 3 ml NS
2.2.1.1. IV; Children: 0.1 mg-01.5 mcg/kg/min for severe anaphlyaxis; 0.01 mg/kg q3-5 min up to 0.2 mg/kg for bradycardia/pulseless arrest
2.3. Endotracheal;Adults & Children: 2-2.5 mg
2.4. Intraspinal;Adults & Children; 0.2-0.4 ml of 1:1000 solution
3. Indications
3.1. Subcut, IV, Inhalation: Management of irreversible airway disease d/t asthma or COPD
3.2. Subcut, IM, IV: Management of severe allergic reactions
3.3. Intratracheal,Intraosseous, Pediatric Advanced Life Support: Management of cardiac arrest
3.4. Inhalation: management of upper airway obstruction and croup
3.5. Local/Spinal: anesthesia
4. Contraindications/Drug Interactions
4.1. Hypersensitivity to adrenergic amines; some inhalers may contain bisulfites or fluorocarbons, avoid in patients with known sensitivites or intolerance
4.2. Use cautiously with: angina, tachycardia, MI, HTN, hyperthyroidism, diabetes, cerebral ateriosclerosis, glaucoma
4.3. Excessive use may result in: tolerance and bronchospasm
4.4. OB: use only if potential maternal benefits outweighs fetal risks, may cause decrease milk production or let down
4.5. Geriatric: more susceptible to adverse reactions (may require lower dose)
4.6. Alcohol, Drugs, CNS depressants, smoking or other respiratory depressants
5. Lab Values
5.1. Normal Range: 1-4 mg
5.2. Toxic Dosage: 7-8 mg
6. Evaluation
6.1. Prevention/relief of bronchospasm, asthma, and increased ease of breathing
6.2. Reversed signs and symptoms of anaphylaxis
6.3. Increase cardiac rate, output, BP, and heart rate
7. Action
7.1. Accumulates cyclic adenosine mono-phosphate (cAMP) at the adrenergic receptors
7.2. This then affects the beta1 (cardiac) adrenergic and beta2 (pulmonary) adrenergic receptor sites
7.2.1. This then causes an increase in heart rate, muscle strength, blood pressure, and bronchodilation